Skip to main content
. 2022 May 16;14(5):1066. doi: 10.3390/pharmaceutics14051066

Figure 14.

Figure 14

Manufacturing capacity by end of 2021 of lead companies producing COVID-19 vaccines. (Vaccine courses are assumed to require two doses) [399].